EBOS Group Limited
17.16
AUD
+0.08
(+0.47%)
ISIN
NZEBOE0001S6
Return %
Stock
S&P 500
1Y
-31.31
14.20
3Y
-45.83
81.12
5Y
-48.47
68.34
Capital Structure
NZD
•
in mil. unless spec.Working Capital
NZD
•
in mil. unless spec.Growth Rates
NZD
•
in mil. unless spec.Semi-annual Revenue
NZD
•
in mil. unless spec.Semi-annual Earnings Per Share
NZD
•
in mil. unless spec.Semi-annual Dividends Per Share
NZD
•
in mil. unless spec.Company Description
- CEO
- Adam Luke Hall
- Full Time Employees
- 6,200
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 737 Bourke Street Docklands VIC Australia 3008
- IPO Date
- Jun 16, 1986
- Website
- ebosgroup.com
- Similar Companies
- Business
- EBOS Group Limited is the largest and most diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, pharmaceutical, and animal care products. Founded in 1922 and headquartered in Sydney, Australia, EBOS operates primarily across Australia, New Zealand, and Southeast Asia through two main segments: Healthcare and Animal Care. The Healthcare segment supplies medical consumables, pharmaceutical products, healthcare logistics, medication management solutions, pharmacy management software, loyalty programs, generics, compliance and business intelligence services, and health communications, programs, and consultancy. The Animal Care segment includes the sale and distribution of animal care products, encompassing both own manufactured and contract manufactured brands, retail and wholesale activities, as well as new product development in pet nutrition and care under brands such as Black Hawk and VitaPet. In recent years, EBOS Group has sustained significant growth through a strategic combination of organic expansion and acquisitions. In FY24, the company surpassed AU$13 billion in total revenue, supported by acquisitions including New Zealand's Superior Pet Food Company in 2023 and several smaller bolt-on acquisitions. EBOS expanded its Community Pharmacy division, growing the TerryWhite Chemmart network to approximately 600 stores across Australia and increased market share in institutional healthcare and contract logistics services. Additionally, the Group launched new products in the animal care category, including the Black Hawk Healthy Benefits dry dog food range and VitaPet dry dog food expansion into major supermarkets, reflecting its innovation focus and investment in new product development. EBOS also continues to emphasize cost efficiency and sustainability initiatives such as large-scale solar energy installations and sustainable packaging transitions. EBOS operates through various subsidiaries and brands, including Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal, serving a broad customer base covering community pharmacies, hospitals, and animal healthcare providers. The company remains committed to strategic growth via selective acquisitions, operational investments, and leveraging its diversified operations to navigate changing market dynamics in the Australasian healthcare and animal care sectors. Its leadership continues to drive initiatives focused on expanding revenue streams, enhancing operational efficiencies, and supporting sustainability goals within all business units. This comprehensive operational and strategic approach positions EBOS Group Limited as a leading integrated healthcare and animal care supply chain partner across the Asia-Pacific region.
Company News
EBOS Group Limited (EBOSY) Shareholder/Analyst Call Transcript
EBOS Group Limited (EBOSY) Q4 2026 Earnings Call Transcript
EBOS Group Limited (EBOSY) Analyst/Investor Day Transcript
EBOS Group Limited (EBOSF) Q2 2026 Earnings Call Transcript